Adicet Bio, Inc. (ACET)

Adicet Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	24.99	9.73	17.9	1
Revenue Growth (YoY)	-	156.83%	-45.65%	1699.30%	-87.84%
Gross Profit	0	24.99	9.73	17.9	1
Selling, General & Admin	26.53	26.3	22.22	22.76	8.69
Research & Development	106.04	71.25	48.94	34.33	23.69
Other Operating Expenses	19.46	0	0	0	0
Operating Expenses	152.04	97.54	71.16	57.09	32.38
Operating Income	-152.04	-72.55	-61.43	-39.19	-31.39
Interest Expense / Income	0.03	0.08	0.18	0.13	0
Other Expense / Income	-9.41	-2.84	0.52	0.17	-3.27
Pretax Income	-142.66	-69.79	-62.12	-39.49	-28.12
Income Tax	0	0	-0.13	-2.82	0.02
Net Income	-142.66	-69.79	-62	-36.68	-28.14
Shares Outstanding (Basic)	43	41	31	7	2
Shares Outstanding (Diluted)	43	41	31	7	2
Shares Change	4.78%	32.72%	322.84%	242.22%	9.86%
EPS (Basic)	-3.31	-1.70	-2.00	-5.01	-13.15
EPS (Diluted)	-3.31	-1.70	-2.00	-5.01	-13.15
Free Cash Flow	-98.18	-61.55	-64.1	-42.54	-28.83
Free Cash Flow Per Share	-2.28	-1.50	-2.07	-5.81	-13.48
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-290.32%	-631.38%	-218.91%	-3154.57%
Profit Margin	-	-279.27%	-637.19%	-204.87%	-2827.94%
Free Cash Flow Margin	-	-246.29%	-658.77%	-237.62%	-2897.89%
EBITDA	-133.69	-64.7	-57.88	-37.41	-26.88
EBITDA Margin	-	-258.91%	-594.87%	-208.95%	-2701.61%
Depreciation & Amortization	8.94	5.01	4.07	1.95	1.24
EBIT	-142.63	-69.71	-61.95	-39.36	-28.12
EBIT Margin	-	-278.95%	-636.67%	-219.85%	-2826.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).